Rothia mucilaginosa Pneumonia in an Immunocompromised Patient: Diagnosis With Plasma Microbial Cell-Free DNA Next-Generation Sequencing and Treatment With Eravacycline

被引：0

作者：

Gelfand, Michael S. ^{[1
]}

Cleveland, Kerry O. ^{[1
]}

Animalu, Chinelo ^{[1
]}

机构：

[1] Univ Tennessee, Hlth Sci Ctr, Div Infect Dis, Dept Med, 1325 Easmoreland Ave,Ste 460, Memphis, TN 38104 USA

来源：

INFECTIOUS DISEASES IN CLINICAL PRACTICE | 2024年 / 32卷 / 06期

关键词：

Rothia pneumonia; eravacycline; next-generation sequencing; BACTEREMIA; EXPERIENCE;

D O I：

10.1097/IPC.0000000000001410

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Rothia mucilaginosa is a gram-positive coccus recognized as an opportunistic pathogen capable of causing pneumonia in immunocompromised patients (Antimicrob Agents Chemother. 1995;39:268-270). The organism is often resistant to fluoroquinolones and trimethoprim/sulfamethoxazole, agents routinely used as anti-infective prophylaxis in immunocompromised individuals (Inf Dis Clin Pract. 2020;28:361-365; Infect Dis Now. 2021;51:228-235). Plasma next-generation sequencing (NGS) is increasing in clinical use to aid in diagnosis of infections in immunocompromised patients (Infect Dis (Lond). 2015;47:125-1299). A patient with advanced multiple myeloma was admitted with pneumonia. Plasma NGS initially suggested R. mucilaginosa, which was confirmed by cultures of bronchoalveolar lavage (BAL) fluid. Treatment with eravacycline led to clinical and radiographic resolution of pneumonia.

引用

页数：2

共 50 条

[31] Clinical Utility of Metagenomic Next-Generation Sequencing of Plasma Microbial Cell-Free DNA: a Single-Center Retrospective Study
Almeida, Guilherme Gomide
Dumm, Rebekah
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162
[32] Plasma metagenomic next-generation sequencing of microbial cell-free DNA detects pathogens in patients with suspected infected pancreatic necrosis
Donghuang Hong
Wang, Peng
Zhang, Jingzhu
Li, Kaiwei
Ye, Bo
Li, Gang
Zhou, Jing
Tong, Zhihui
Ke, Lu
Shi, Songjing
Li, Weiqin
BMC INFECTIOUS DISEASES, 2022, 22 (01)
[33] CELL-FREE NEXT-GENERATION SEQUENCING FOR DIAGNOSIS OF INFECTION IN HOSPITALIZED PEDIATRIC PATIENTS
Wilke, Julianne
Farnaes, Lauge
Bradley, John
Harvey, Helen
Hong, David
Coufal, Nicole
CRITICAL CARE MEDICINE, 2020, 48
[34] NEXT-GENERATION SEQUENCING OF PLASMA DNA FOR MOLECULAR DIAGNOSIS
Lo, Y. M. D.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S20 - S20
[35] The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA
Nix, David A.
Hellwig, Sabine
Conley, Christopher
Thomas, Alun
Fuertes, Carrie L.
Hamil, Cindy L.
Bhetariya, Preetida J.
Garrido-Laguna, Ignacio
Marth, Gabor T.
Bronner, Mary P.
Underhill, Hunter R.
PLOS ONE, 2020, 15 (02):
[36] The Economics of Cell-Free DNA Metagenomic Next-Generation Sequencing for Pathogen Detection
Yang, Shangxin
CLINICAL CHEMISTRY, 2025,
[37] Intestinal mucormycosis initially identified by next-generation sequencing of cell-free DNA
Martin-Blais, Rachel
Pathak, Saumya
Fitzwater, Sean
Dawson, David W.
Sisk, Anthony E.
Farmer, Douglas G.
Venick, Robert
Yeganeh, Nava
TRANSPLANT INFECTIOUS DISEASE, 2021,
[38] The stochastic nature of errors in next-generation sequencing of circulating cell-free DNA
Underhill, Hunter R.
Bhetariya, Preetida J.
Hellwig, Sabine
Nix, David A.
Fuertes, Carrie L.
Marth, Gabor T.
Bronner, Mary P.
CANCER RESEARCH, 2019, 79 (13)
[39] Primary exploration of cell-free DNA in the plasma of patients with parathyroid neoplasms using next-generation sequencing
Zheng, Qingyuan
Cui, Ming
Wang, Ou
Chang, Xiaoyan
Xiao, Jinheng
Chen, Tianqi
Wang, Mengyi
Hua, Surong
Hu, Ya
Liao, Quan
CANCER CELL INTERNATIONAL, 2025, 25 (01)
[40] Clinical impact of a metagenomic microbial plasma cell-free DNA next-generation sequencing assay on treatment decisions: a single-center retrospective study
Akira A. Shishido
Myint Noe
Kapil Saharia
Paul Luethy
BMC Infectious Diseases, 22

← 1 2 3 4 5 →